ADC Therapeutics
ADCT
ADCT
60 hedge funds and large institutions have $149M invested in ADC Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $177M → $149M (-$27.4M)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
48% less call options, than puts
Call options by funds: $21K | Put options by funds: $40K
Holders
60
Holding in Top 10
1
Calls
$21K
Puts
$40K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$8.19M | |
| 3 | +$7.48M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.14M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.71M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$11.5M | |
| 3 | -$2.41M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$2.18M |
| 5 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
-$1.93M |